Pharmacological characterization of a specific binding site for angiotensin IV in cultured porcine aortic endothelial cells

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 193-199

  Riva, Laurence ^a   Galzin, Anne Marie ^a  

^a SANOFI   (France)

Author keywords

angiotensin IV binding; aortic endothelial cell; porcine

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; CALCIUM; CHELATING AGENT; DIVALENT CATION; EGTAZIC ACID; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE DERIVATIVE; IODINE 125; LOSARTAN; LOSARTAN POTASSIUM; MAGNESIUM; MANGANESE; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PEPTIDE DERIVATIVE; RECEPTOR SUBTYPE; SARALASIN; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING KINETICS; BINDING SITE; CELL CULTURE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG SPECIFICITY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SWINE;

EID: 0030014140     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00149-5     Document Type: Article

References (30)

1. Baker, K.M. and J.F. Aceto, 1990, Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells, Am. J. Physiol. 259, H610.
2. Bernier, S.G., A. Fournier and G. Guillemette, 1994, A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes, Eur. J. Pharmacol. 271, 53.
3. Bradford, M., 1976, A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
4. Braszko, J.J., G. Kupryszewski, B. Witczuk and K.W. Wisniewski, 1988, Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27, 777.
5. 50) of an enzymatic reaction, Biochem. Pharmacol. 22, 3099.
6. Dostal, P.E., T. Murahashi and M.J. Peach, 1990, Regulation of cytosolic calcium by angiotensins in vascular smooth muscle, Hypertension 15, 815.
7. Ferrario, C.M., K.B. Brosnihan, D.I. Diz, N. Jaiswal, M.C. Khosla, A. Milsted and A. Tallant, 1991, Angiotensin-(1-7): a new hormone of the angiotensin system, Hypertension 18, 111.
8. Gardiner, S.M., P.A. Kemp, J.E. March and T. Bennett, 1993, Regional haemodynamic effects of angiotensin II(3-8) in conscious rats, Br. J. Pharmacol. 110, 159.
9. Gehlert, D.R., S.L. Gackenheimer and D.A. Shober, 1991, Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to AII-1 and enhances to AII-2, Brain Res. 546, 161.
10. Giddings, J.C., A.L. Jarvis and A.L. Bloom, 1983, Differential localisation and synthesis of porcine factor VIII related antigen (VIIIR:AG) in vascular endothelium and in endothelial cells in culture, Thromb. Res. 29, 299.
11. Haberl, R.L., P.J. Decker and K.M. Einhäupl, 1991, Angiotensin degradation products mediate endothelium-dependent dilatation of rabbit brain arterioles, Circ. Res. 68, 1621.
12. Hall, K., J. Hanesworth, M. Schelling, H. Hosick, J. Coleman, J. Wright and J. Harding, 1992, Characterization of a specific binding site for the hexapeptide fragment of angiotensin II (AIV) in cultured bovine vascular cells, FASEB J. 6, A1822, 5129.
13. Hall, K.L., J.M. Hanesworth, A.E. Ball, G.P. Felgenhauer, H.L. Hosick and J.W. Harding, 1993, Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV, Regul. Pept. 44, 225.
14. Hanesworth, J.M., M.F. Sardinia, L.T. Krebs, K.L. Hall and J.W. Harding, 1993, Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes, J. Pharmacol. Exp. Ther. 266, 1036.
15. Harding, J.W., V.I. Cook, A.V. Miller-Wing, J.M. Hanesworth, M.F. Sardinia, K.L. Hall, J.W. Stobb, G.N. Swanson, J.K.M. Coleman, J.W. Wright and E.C. Harding, 1992, Identification of an AII(3-8)[AIV] binding site in guinea pig hippocampus, Brain Res. 583, 340.
16. Jaffe, E.A., R.L. Nachman, C.G. Becker and C.R. Minick, 1973, Culture of human endothelial cells derived from ombilical veins: identification by morphologic and immunologic criteria, J. Clin. Invest. 52, 2745.
17. 4 receptors in bovine adrenal cortex, Peptides 15, 1037.
18. Johnson, C.I, 1990, Biochemistry and pharmacology of the renin-angiotensin system, Drugs 39, 21.
19. Miller-Wing, A.V., J.W. Stobb, V.I. Cook, E.C. Harding and J.W. Harding, 1992, Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor, Regul. Pept. 40, 409.
20. Miller-Wing, A.V., J.M. Hanesworth, M.F. Sardinia, L.H. Keith, J.W. Wright, R.C. Speth, K.L. Grove and J.W. Harding, 1993, Central angiotensin IV binding and specificity in guinea pig brain, J. Pharmacol. Exp. Ther. 266, 1718.
21. Munson, P.J. and D. Rodbard, 1980, LIGAND: a versatile computerized approach to characterization of ligand binding systems, Anal. Biochem. 107, 220.
22. 2 receptor: searching for signal-transduction pathways and physiological function, 1995, Trends Pharmacol. Sci. 16, 223.
23. Roberts, K.A., L.T. Krebs, E.A. Kramar, M.J. Shaffer, J.W. Harding and J.W. Wright, 1995, Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats, Brain Res. 682, 13.
24. 4 receptor with high affinity, FASEB J. 8, 5097.
25. 4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues, Peptides 15, 1399.
26. Swanson, G.N., J.M. Hanesworth, M.F. Sardinia, J.K.M. Coleman, J.W. Wright, K.L. Hall, A.V. Miller-Wing, J.W. Stobb, V.I. Cook, E.C. Harding and J.W. Harding, 1992, Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor, Regul. Pept. 40, 409.
27. Timmermans, P.B.M.W.M., P.C. Wong, A.T. Chiu and W.F. Herblin, 1991, Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol. Sci. 12, 55.
28. Whitebread, S, M. Mele, B. Kamber and M. de Gasparo, 1989, Preliminary biochemical characterization of two angiotensin II receptor subtypes, Biochem. Biophys. Res. Commun. 163, 284.
29. Wong, P.C., S.D. Hart, A.M. Zaspel, A.T, Chiu, R.J. Ardecky, R.D. Smith and P.B.M.W.M. Timmermans, 1990, Functional studies of nonpeptide angiotensin II receptor subtype specific ligands: DuP 753 (AII-1) and PD 123177 (AII-2), J. Pharmacol. Exp. Ther. 255, 584.
30. Wright, J.W., L.T. Krebs, J.W. Stobb and J.W. Harding, 1995, The angiotensin IV system: functional implications. Front. Neuroendocrin. 16, 23.